Table 4.
Characteristics | All subjects | CCs group | Non-CCs group | p-value |
---|---|---|---|---|
(n = 269) | (n = 105) | (n = 164) | CCs vs. non-CCs | |
MLA (mm2) | 3.13 ± 2.07 | 2.34 ± 1.29 | 3.63 ± 2.31 | < 0.001 |
PLA (mm2) | 9.08 ± 3.10 | 8.47 ± 2.74 | 9.47 ± 3.26 | 0.010 |
DLA (mm2) | 7.17 ± 3.11 | 6.69 ± 2.86 | 7.46 ± 3.23 | 0.046 |
ALA (mm2) | 8.128 ± 2.89 | 7.58 ± 2.53 | 8.46 ± 3.06 | 0.014 |
Lesion length (mm) | 17.98 ± 8.16 | 20.33 ± 9.36 | 16.48 ± 6.90 | <0.001 |
DS (%) | 62.26 ± 16.33 | 68.92 ± 12.50 | 57.99 ± 17.08 | 0.002 |
Lipid-rich plaque (n, %) | 230 (85.5) | 93 (88.6) | 137 (83.5) | 0.290 |
Lipid length (mm) | 13.63 ± 9.10 | 15.58 ± 9.98 | 12.38 ± 8.28 | 0.005 |
Maximal lipid arc (°) | 224.35 ± 109.53 | 252.24 ± 110.16 | 206.50 ± 105.65 | 0.001 |
TCFA (n, %) | 75 (27.8) | 54 (51.4) | 21 (12.8) | < 0.001 |
Thrombus (n, %) | 66 (24.5) | 39 (37.1) | 27 (16.4) | 0.026 |
Macrophage (n, %) | 167 (62.1) | 89 (84.8) | 78 (47.6) | <0.001 |
Plaque rupture (n, %) | 38 (14.1) | 26 (24.8) | 12 (7.3) | <0.001 |
Micro channel (n, %) | 97(36.0) | 59(56.2) | 38(23.2) | <0.001 |
Calcification (n, %) | 101(37.5) | 49(46.7) | 52(31.7) | 0.015 |
Spotty calcification (n, %) | 96(35.7) | 47(44.8) | 49(29.9) | 0.019 |
Large calcification (n, %) | 56(20.8) | 27(25.7) | 29(17.7) | 0.125 |
Layered plaque (n %) | 117(43.5) | 74(70.5) | 43(26.2) | <0.001 |
MLA, minimum luminal area; PLA, proximal luminal area; DLA, distal luminal area; ALA, average luminal area; DS, diameter stenosis; TCFA, thin-capped fibroatheroma, CCs, cholesterol crystals.